Alphamab Oncology
SEHK:9966
HK$ 5.20
HK$-0.03 (-0.57%)
HK$ 5.20
HK$-0.03 (-0.57%)
End-of-day quote: 05/13/2024

9966 - Alphamab Oncology Stock Prediction 2025 - 2030

4 years of reliable Alphamab Oncology stock forecast. The Wall Street analysts predict Hold for 9966. See at a glance whether SEHK:9966 will rise in the future.

HK$0.00
Forecast 2023
HK$6.02
Forecast 2025
HK$9.42
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
HK$0.00
Forecast 2025
HK$6.02
Forecast 2030
HK$9.42
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.36
Price-to-book Ratio
2.92
Market Cap
4.58B
TEV
6.19 B
Dividend
HK$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
HK$7.92
Country

Alphamab Oncology Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Alphamab Oncology Stock Forecast 2023

HK$3.33

In the last five quarters, Alphamab Oncology’s Price Target has fallen from HK$26.48 to HK$7.92 - a -70.09% decrease. Four analysts predict that Alphamab Oncology’s share price will fall in the coming year, reaching HK$3.33. This would represent a decrease of -57.95%.

-35.96%
-35.96
Last update: 05/14/2024

Highest Price Target HK$4.43

Average Price Target HK$3.33

Lowest Price Target HK$3.14

Alphamab Oncology Stock Forecast 2025

Stock Prediction for the Price of One Alphamab Oncology Share in Jan 2025.

In Jan 2025 analysts predict a share price of HK$5.55. An increase of 6.73% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Feb 2025.

In Feb 2025 analysts predict a share price of HK$5.59. An increase of 7.56% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Mar 2025.

In Mar 2025 analysts predict a share price of HK$5.64. An increase of 8.38% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Apr 2025.

In Apr 2025 analysts predict a share price of HK$5.68. An increase of 9.21% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in May 2025.

In May 2025 analysts predict a share price of HK$5.72. An increase of 10.03% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Jun 2025.

In Jun 2025 analysts predict a share price of HK$5.76. An increase of 10.86% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Jul 2025.

In Jul 2025 analysts predict a share price of HK$5.81. An increase of 11.69% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Aug 2025.

In Aug 2025 analysts predict a share price of HK$5.85. An increase of 12.51% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Sep 2025.

In Sep 2025 analysts predict a share price of HK$5.89. An increase of 13.34% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Oct 2025.

In Oct 2025 analysts predict a share price of HK$5.94. An increase of 14.16% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Nov 2025.

In Nov 2025 analysts predict a share price of HK$5.98. An increase of 14.99% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Dec 2025.

In Dec 2025 analysts predict a share price of HK$6.02. An increase of 15.82% compared to today's share price.

Alphamab Oncology Stock Predictions 2030

Alphamab Oncology Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of HK$8.68. An increase of 66.95% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of HK$8.75. An increase of 68.24% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of HK$8.82. An increase of 69.53% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of HK$8.88. An increase of 70.82% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of HK$8.95. An increase of 72.11% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of HK$9.02. An increase of 73.41% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of HK$9.08. An increase of 74.7% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of HK$9.15. An increase of 75.99% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of HK$9.22. An increase of 77.28% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of HK$9.29. An increase of 78.57% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of HK$9.35. An increase of 79.87% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of HK$9.42. An increase of 81.16% compared to the previous month's estimate.

P/E
0.00
Beta
0.36
Price-to-book Ratio
2.92
Market Cap
4.58B
TEV
6.19 B
Dividend
HK$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
HK$7.92
Country

Alphamab Oncology Analyst Ratings Frequently Asked Questions

Who are the analysts watching Alphamab Oncology?

The following analysts have recently covered Alphamab Oncology:

CLSA
Jefferies LLC
Morgan Stanley
Citigroup Inc
Citigroup Inc. Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Alphamab Oncology?

The following sell-side analysts have recently covered Alphamab Oncology:

Yan, Yonglin
Shi, Dingding
Wu, Sean
Zhou, Wangbin
(This information refers to the last 90 days.)